CAS: 75219-46-4 - Atrimustine
Formel:C41H47Cl2NO6
InChl:InChI=1S/C41H47Cl2NO6/c1-41-21-20-34-33-17-15-32(49-40(47)29-7-3-2-4-8-29)26-30(33)12-16-35(34)36(41)18-19-37(41)50-39(46)27-48-38(45)9-5-6-28-10-13-31(14-11-28)44(24-22-42)25-23-43/h2-4,7-8,10-11,13-15,17,26,34-37H,5-6,9,12,16,18-25,27H2,1H3/t34-,35-,36+,37+,41+/m1/s1
InChI Key:InChIKey=IFJUINDAXYAPTO-UUBSBJJBSA-N
SMILES:O=C(OC1=CC=C2C(=C1)CCC3C2CCC4(C)C(OC(=O)COC(=O)CCCC5=CC=C(C=C5)N(CCCl)CCCl)CCC34)C=6C=CC=CC6
- Synonyme:
- (17Beta)-17-({[(4-{4-[Bis(2-Chloroethyl)Amino]Phenyl}Butanoyl)Oxy]Acetyl}Oxy)Estra-1,3,5(10)-Trien-3-Yl Benzoate
- 17β-Busramustine
- Bestrabucil
- Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-benzoate 17-[2-[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]acetate]
- Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-benzoate 17-[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]acetate]
- Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-benzoate 17-[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]acetate], (3β,5β)-
- Km 2210
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
Atrimustine REF: 3D-ADA21946CAS: 75219-46-4 | Min. 95% | Nachfragen | Mo 13 Jan 25 | |
Atrimustine REF: TM-T14344CAS: 75219-46-4 | 98% | 233,00 €~1.727,00 € | Di 21 Jan 25 |
Atrimustine
Ref: 3D-ADA21946
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen |
Atrimustine
Ref: TM-T14344
25mg | 850,00 € | ||
50mg | 1.112,00 € | ||
100mg | 1.727,00 € |